Page last updated: 2024-11-04

sulfisoxazole and Conductive Hearing Loss

sulfisoxazole has been researched along with Conductive Hearing Loss in 1 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Research Excerpts

ExcerptRelevanceReference
"5 to 7 years) who met the usual indications for surgery (long-standing [greater than 3 months] OME and conductive hearing loss) were randomly assigned to "medical" treatment (sulfisoxazole 75 mg/kg per day for 6 months) or "surgical" treatment (bilateral insertion of VTs)."5.07Randomized, controlled trial comparing long-term sulfonamide therapy to ventilation tubes for otitis media with effusion. ( Bernard, PA; Durieux-Smith, A; Feldman, W; Stenstrom, RJ, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernard, PA1
Stenstrom, RJ1
Feldman, W1
Durieux-Smith, A1

Trials

1 trial available for sulfisoxazole and Conductive Hearing Loss

ArticleYear
Randomized, controlled trial comparing long-term sulfonamide therapy to ventilation tubes for otitis media with effusion.
    Pediatrics, 1991, Volume: 88, Issue:2

    Topics: Audiometry, Pure-Tone; Auditory Threshold; Child; Child, Preschool; Female; Hearing Loss, Conductive

1991